Plexiform fibrohistiocytic tumor
| Plexiform fibrohistiocytic tumor | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Oncology, Pathology |
| Symptoms | Painless mass |
| Complications | N/A |
| Onset | Typically in children and young adults |
| Duration | |
| Types | |
| Causes | Unknown |
| Risks | |
| Diagnosis | Histopathology |
| Differential diagnosis | Fibrous histiocytoma, Dermatofibrosarcoma protuberans, Neurofibroma |
| Prevention | |
| Treatment | Surgical excision |
| Medication | |
| Prognosis | Generally benign, but can recur |
| Frequency | Rare |
| Deaths | N/A |
Plexiform fibrohistiocytic tumor (PFHT) is a rare type of soft tissue tumor that typically occurs in children and young adults. It was first described in the medical literature in 1988. PFHT is considered a low-grade malignancy, meaning it has the potential to spread to other parts of the body, but this is uncommon.
Signs and Symptoms[edit]
Patients with PFHT typically present with a slow-growing, painless mass. The most common locations for these tumors are the upper extremities, followed by the head and neck region. However, they can occur anywhere in the body.
Diagnosis[edit]
The diagnosis of PFHT is made based on the findings of a biopsy of the tumor. The tumor is composed of a mixture of fibroblasts and histiocytes, arranged in a distinctive plexiform pattern. The cells are typically spindle-shaped and have a moderate amount of cytoplasm. There may also be areas of necrosis or hemorrhage within the tumor.
Treatment[edit]
The primary treatment for PFHT is surgical removal of the tumor. In some cases, chemotherapy or radiation therapy may be used as well.
Prognosis[edit]
The prognosis for patients with PFHT is generally good, with a high rate of long-term survival. However, the tumor can recur in up to one-third of cases, and metastasis can occur, although this is rare.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
